Just months after announcing a $ 65 million expansion that will boost capacity at the North Carolina facility where it makes diabetes medications, Novo Nordisk says it needs yet more and will top it off with another $ 22 million and another 22 jobs. A Novo spokesman Wednesday confirmed an announcement by development officials in… Read More »
JOHANNESBURG (Reuters) – South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent. The company’s new Emdolten drug is a once-a-day tablet in the form of dolutegravir, an antiretroviral medication that counters the drug resistance that often develops with older… Read More »
Nov. 20, 2018 — The FDA has approved a new prescription drug for traveler’s diarrhea, which affects millions of people a year, cutting short vacations and other trips. Rifamycin (Aemcolo) is expected to be on the market by mid-February, says Tom Joyce, president and CEO of Aries Pharmaceuticals, the U.S. firm licensed to distribute it… Read More »